Filter

251-260 of 390 results

  • Express Lane Eligibility Efforts: Lessons Learned from Early State Cross-Program Enrollment Initiatives

    Issue Brief

    The Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA) provides states new options to reach and enroll eligible but uninsured low-income children into Medicaid and CHIP. The law's Express Lane Eligibility (ELE) provisions enable state Medicaid and CHIP agencies to identify, enroll and recertify children by relying on eligibility findings from other programs, such as Head Start or Food Stamps, rather than having to re-analyze eligibility under their own rules. Further, CHIPRA authorizes greater…

  • Coverage of Low-Income Children: Key Issues to Consider in Health Reform

    Issue Brief

    A key element of health reform will be meeting the needs of low-income children. Overall, a major goal of proposals is to expand coverage by building on Medicaid, providing subsidies to low- and moderate-income individuals to buy coverage through new health insurance exchanges, and requiring individuals to obtain coverage. Current proposals also could significantly change coverage for some children already eligible for Medicaid and CHIP. This issue brief examines several key issues to consider about…

  • Access to Care for S-CHIP Children with Special Health Needs

    Issue Brief

    A study of California, Connecticut, Maryland, Missouri, and Utah CHIP programs show that the states have features in place for special needs children, but problems of provider availability and service authorization did sometimes occur. This is the first in a series of reports on implementation issues and challenges in the first year of CHIP. ISSUE BRIEF Download

  • Health Insurance for Unemployed Workers

    Event Date:
    Event

    Submitted testimony of Diane Rowland, executive director of the Commission, about health insurance options for unemployed workers. She was scheduled to testify to the U.S. Senate Committee on Health, Education, Labor, and Pensions, but the hearing was postponed.

  • Medicaid Enrollment Churn and Implications for Continuous Coverage Policies

    Issue Brief

    Recent policy actions and proposals in Medicaid have renewed focus on the problem of churn, or temporary loss of coverage in which enrollees disenroll and then re-enroll within a short period of time. We find that 10% of full-benefit enrollees have a gap in coverage of less than a year, and rates are higher for children and adults compared to aged and people with disabilities. Churn has implications for access to care as well as…

  • KFF COVID-19 Vaccine Monitor: January 2022 Parents And Kids Update

    Poll Finding

    This Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.

  • Diversity of Under-5 Age Group Varies Across States

    Feature

    Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.

  • Four in Ten Parents of School-Aged Children Say a Child Fell Behind Academically Due to the COVID-19 Pandemic

    News Release

    Four in Ten Parents Say Someone in Their Household Left a Job or Worked Fewer Hours to Care for Their Children, Including Higher Shares of Black, Hispanic, and Lower-income Parents As a result of the pandemic, about four in ten (39%) parents of school-aged children (ages 5-17) say at least one of their children fell behind academically, rising to half among parents with household incomes below $40,000 (51%) and Hispanic parents (50%), a new KFF…

  • Policy Considerations as Children Ages 5-11 Become Eligible for the COVID-19 Vaccine

    News Release

    A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children. A final FDA decision, and Centers for Disease Control and Prevention actions, will follow as soon as the first week in November. As the Biden administration plans…